Welcome to Francis Academic Press

International Journal of Frontiers in Medicine, 2024, 6(2); doi: 10.25236/IJFM.2024.060211.

Research progress and prospect on the mechanism of extracellular matrix remodeling based on myocardial cells

Author(s)

Yun Niu1,2, Yingying Tan1

Corresponding Author:
Yingying Tan
Affiliation(s)

1Basic Medical College, Shaanxi University of Traditional Chinese Medicine, Xianyang, Shaanxi, 712000, China

2General Outpatient Department, Aviation Industry Corporation of China First Aircraft Institute, Xi'an, Shaanxi, 710089, China

Abstract

Cardiovascular disease is the most lethal disease in all kinds of diseases in the world, and it has important global public health significance for its prevention and treatment. Myocardial fibrosis is one of the typical pathological manifestations of cardiovascular disease, which seriously affects the diastolic and systolic function of the ventricle and ultimately leads to heart failure. The matrix of cells surrounding cardiomyocytes has an important role in controlling cell proliferation, differentiating, and preserving the structural and functional integrity of the heart. The predominant factor contributing to myocardial fibrosis is the dysregulation of collagen homeostasis within the cardiomyocyte extracellular matrix. Therefore, preventing and reversing myocardial extracellular matrix remodeling has become an important goal for improving cardiac dysfunction and treating cardiovascular diseases. Modern studies have found that its reconstruction is often related to the expression of multiple pathways and the regulation of related factors. Based on this, together with the advancements in traditional Chinese and Western medical treatment, new concepts for enhancing cardiac function and patient quality of life are predicted to emerge.

Keywords

Cardiomyocyte extracellular matrix; Myocardial fibrosis; Cardiovascular disease; Integration of traditional Chinese medicine and Western medicine

Cite This Paper

Yun Niu, Yingying Tan. Research progress and prospect on the mechanism of extracellular matrix remodeling based on myocardial cells. International Journal of Frontiers in Medicine (2024), Vol. 6, Issue 2: 72-77. https://doi.org/10.25236/IJFM.2024.060211.

References

[1] Ma Liyuan, Wang Zengwu, Fan Jing, et al. Summary of China Cardiovascular Health and Disease Report 2021 [J]. Chinese Journal of Interventional Cardiology, 2022,30 (07): 481-496.

[2] Yu Rui, Wang Youping, Cui Lin, and others research on the pathogenesis and progress of myocardial fibrosis [J]. Chinese Modern Doctor, 2015, 53 (13): 157-160.

[3] FRANGOGIANNIS N G.The Extracellular Matrix in Ischemic and Nonischemic Heart Failure [J].Circulation Research, 2019, 125(1): 117-146.

[4] RUSSO I, CAVALERA M, HUANG S, et al.Protective Effects of Activated Myofibroblasts in the Pressure-Overloaded Myocardium Are Mediated Through Smad-Dependent Activation of a Matrix-Preserving Program [J].Circ Res, 2019,124(8): 1214-1227.

[5] Han Anbang, Zhang Jian, Lu Yingdong, etc. Qiliqiangxin capsule on myocardial fibrosis and TGF-β1/Smad 3 signaling pathway in rats with myocardial infarction [J]. Journal of Beijing University of Traditional Chinese Medicine, 2017,40 (01): 41-47.

[6] MA J, MA S Y, DING C H.Curcumin reduces cardiac fibrosis by inhibiting myofibroblast differentiation and decreasing transforming growth factor β1 and matrix metalloproteinase 9 / tissue  inhibitor of metalloproteinase 1 [J].Chin J Integr Med, 2017,23(5): 362-369.

[7] Li A.A. Inflammatory mechanism of peroxisome proliferator-activated receptor on myocardial extracellular matrix remodeling [D]. Shandong University, 2006.

[8] Xiaoyang Hou, Research on the molecular regulation mechanism of peroxidase proliferator-activated receptor γ in myocardial extracellular matrix remodeling [D]. Shandong University, 2006.

[9] FAN D, TAKAWALE A, BASU R, et al.Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction[J].Cardiovasc Res, 2014,103(2): 268-280.

[10] SPINALE F G.Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function[J].Physiol Rev, 2007,87(4): 1285-1342.

[11] Juan Zhao, Yu Xiaoshuo, Xiaoyu Yu, and other serum expression and correlation of MMP-2, MMP-9 and NT-proBNP in patients with chronic heart failure [J]. Journal of Modern Integrated Traditional Chinese and Western Medicine, 2018, 27 (35): 3941-3945.

[12] Yuxia Li, Effect of Jiang Shanrosuvastatin on the expression of MMP-2 and MMP-9 protein in cardiac hypertrophy of the rats [J]. New Medicine, 2010, 41 (08): 531-534.

[13] Liu Shengquan. Hydrogen sulfide ameliorates hyperhomocysteinemia-induced myocardial fibrosis by down-regulating TGF-β1/Smad3 signaling pathway [D]. Nanhua University, 2019.

[14] BARTEKOVA M, RADOSINSKA J, JELEMENSKY M, et al. Role of cytokines and inflammation in heart function during health and disease [J].Heart Fail Rev, 2018, 23(5): 733-758.

[15] HANNA A, HUMERES C, FRANGOGIANNIS N G.The role of Smad signaling cascades in cardiac fibrosis [J].Cell Signal, 2021, 77: 109826.

[16] Zhang L. Changes of TGF-β1/Smad signaling pathway expression in myocardial tissues of diabetic rats and intervention study [D]. Tianjin Medical University, 2012.Lin Zhang. Expression changes and intervention study of TGF-β1/Smad signaling pathway in myocardial tissue of diabetic rats [D]. Tianjin Medical University, 2012.

[17] PETROV V V, FAGARD R H, LIJNEN P J.Stimulation of collagen production by transforming growth factor-beta1 during differentiation of cardiac fibroblasts to myofibroblasts [J].Hypertension, 2002,39(2): 258-263.

[18] HU S Y, ZHOU Y, ZHONG S J, et al.Shenmai Injection Improves Hypertensive Heart Failure by Inhibiting Myocardial Fibrosis via TGFβ1/Smad Pathway Regulation [J].Chin J Integr Med, 2023 Feb;29(2):119-126.

[19] MA Y, de CASTRO B L, TOBA H, et al.Myofibroblasts and the extracellular matrix network in post-myocardial infarction cardiac remodeling [J].Pflugers Arch, 2014,466(6): 1113-1127.

[20] ZHANG Yan, LI Miao, LIU Jing, et al. Progress of TGF-β/Smads signaling pathway in hypertensive myocardial fibrosis [J]. Hebei Medicine, 2021, 27(06): 1053-1056.

[21] FRANGOGIANNIS N G.Chemokines in the ischemic myocardium: from inflammation to fibrosis [J].Inflamm Res, 2004, 53(11): 585-595.

[22] SCHAEFER L.Decoding fibrosis: Mechanisms and translational aspects [J].Matrix Biol, 2018, 68-69: 1-7.

[23] CHEN D Q, FENG Y L, CAO G, et al.Natural Products as a Source for Antifibrosis Therapy [J].Trends Pharmacol Sci, 2018,39(11): 937-952.

[24] LI X, LI L, LEI W, et al.Traditional Chinese medicine as a therapeutic option for cardiac fibrosis:  Pharmacology and mechanisms [J].Biomed Pharmacother, 2021,142: 111979.

[25] Li Jianfeng. Study on the effective site and its signaling pathway of Allium guajava Allium sativum soup to protect ischemic and hypoxic cardiomyocytes [D]. Shandong University of Traditional Chinese Medicine, 2016.